Judith S. Currier

20.6k citations

294 papers · 12.2k indexed · 2 hit papers · h-index 51

Virology top 0.05%
- HIV Research and Treatment 98
Emergency Medicine top 0.02%
- HIV-related health complications and treatments 141
Infectious Diseases top 0.05%
- HIV/AIDS Research and Interventions 117
- HIV/AIDS drug development and treatment 106
Epidemiology top 0.5%
- Pneumocystis jirovecii pneumonia detection and treatment 29
- HIV, Drug Use, Sexual Risk 16
Hepatology top 2%
- Hepatitis C virus research 16
Endocrinology, Diabetes and Metabolism
- Diabetes, Cardiovascular Risks, and Lipoproteins 18

Co-authors: Michael D. Hughes James H. Stein Kathleen Squires Scott M. Hammer Joseph J. Eron Judith A. Aberg Judith Feinberg Margaret A. Fischl
Cited by: Virology Emergency Medicine Infectious Diseases
Journals: New England Journal of Medicine (3 papers)Proceedings of the National Academy of Sciences (1 paper)The Lancet (2 papers)
Partner nations: United States South Africa Zimbabwe

In The Last Decade

Judith S. Currier

274 papers receiving 11.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Judith S. Currier

Since Specialization

Citations

This map shows the geographic impact of Judith S. Currier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith S. Currier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith S. Currier more than expected).

Fields of papers citing papers by Judith S. Currier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith S. Currier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith S. Currier. The network helps show where Judith S. Currier may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Judith S. Currier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Judith S. Currier Line = papers co-authored together Judith S. Currier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Statin-dependent and -independent pathways are associated with major adverse cardiovascular events in people with HIV Journal of Clinical Investigation ·Márton Kolossváry,Irini Sereti,Markella V. Zanni,Carl J. Fichtenbaum,Judith A. Aberg,Gerald S. Bloomfield,Carlos Malvestutto,Judith S. Currier,Sarah M Chu,Marissa R Diggs,Amy Shirong Lu,Christopher R. deFilippi,Borek Foldyna,Sara McCallum,Craig A. Sponseller,Michael T. Lu,Pamela S. Douglas,Heather J. Ribaudo,Steven Grinspoon	2025	0
2	How HIV research drives health innovation in multiple diseases Nature Medicine ·Lawrence Corey,Jirair Ratevosian,Chris Beyrer,Judith S. Currier,Joseph J. Eron,Myron S. Cohen,Steven G. Deeks	2025	0
3	Risk Assessment in a Global CVD Prevention Cohort of People With HIV by PCE, PREVENT, and SCORE2 Clinical Infectious Diseases ·Steven Grinspoon,Sophia Zhao,Estebán Martínez,Carl J. Fichtenbaum,Sarah M Chu,Marissa R Diggs,Triin Umbleja,Sara McCallum,Kathleen V. Fitch,Virginia A. Triant,Judith S. Currier,Judith A. Aberg,Carlos Malvestutto,Kristine M. Erlandson,Gerald S. Bloomfield,Michael T. Lu,Pamela S. Douglas,Heather J. Ribaudo,Markella V. Zanni	2025	0
4	Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort Open Forum Infectious Diseases ·Emma Smith,Carlos Malvestutto,Heather J. Ribaudo,Carl J. Fichtenbaum,Judith A. Aberg,Maya Watanabe,Gerald S. Bloomfield,Judith S. Currier,Sarah M Chu,Kathleen V. Fitch,Marissa R Diggs,Roger Bedimo,Javier Valencia,Cristina Gómez‐Ayerbe,Indira Brar,José Valdez Madruga,Michael T. Lu,Pamela S. Douglas,Markella V. Zanni,Steven Grinspoon	2025	0
5	Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the future Journal of Clinical and Translational Science ·Stacey J. Adam,Timothy G. Buchman,Judith S. Currier,Ruxandra Draghia‐Akli,Joshua P. Fessel,Elizabeth S. Higgs,Eric Hughes,Lisa M. LaVange,Joseph P. Menetski,Sarah W. Read,Yves Rosenberg,Randall Tressler	2024	0
6	The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials SHILAP Revista de lepidopterología ·Kristian Thorlund,Davey M. Smith,Christopher Linsell,Nicholas J. White,Christopher Butler,David R. Boulware,Judith S. Currier,Ofir Harari,Edouard Lhomme,Nathalie Strub‐Wourgaft,Stacey J. Adam,Edward J. Mills	2023	5
7	Identification of pre-infection markers and differential plasma protein expression following SARS-CoV-2 infection in people living with HIV EBioMedicine ·Márton Kolossváry,Christopher R. deFilippi,Sara McCallum,Kathleen V. Fitch,Marissa R Diggs,Evelynne S. Fulda,Heather J. Ribaudo,Carl J. Fichtenbaum,Judith A. Aberg,Carlos Malvestutto,Judith S. Currier,Jose L. Casado,Félix Gutiérrez,Irini Sereti,Pamela S. Douglas,Markella V. Zanni,Steven Grinspoon	2023	2
8	Prevalence and Factors Associated With Antigen Test Positivity Following SARS-CoV-2 Infection Among Health Care Workers in Los Angeles Open Forum Infectious Diseases ·Paul C. Adamson,Judith S. Currier,Daniel Z. Uslan,Omai B. Garner	2022	2
9	Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy The Journal of Infectious Diseases ·Márton Kolossváry,Christopher R. deFilippi,Michael T. Lu,Markella V. Zanni,Evelynne S. Fulda,Borek Foldyna,Heather J. Ribaudo,Thomas Mayrhofer,Ann C. Collier,Gerald S. Bloomfield,Carl J. Fichtenbaum,Edgar T. Overton,Judith A. Aberg,Judith S. Currier,Kathleen V. Fitch,Pamela S. Douglas,Steven Grinspoon	2022	9
10	Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses JCI Insight ·Sydney I. Ramirez,Alba Grifoni,Daniela Weiskopf,Urvi M. Parikh,Amy Heaps,Farhoud Faraji,Scott F. Sieg,Justin Ritz,Carlee Moser,Joseph J. Eron,Judith S. Currier,Paul Klekotka,Alessandro Sette,David A. Wohl,Eric S. Daar,Michael D. Hughes,Kara W Chew,Davey M. Smith,Shane Crotty	2022	5
11	Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus Open Forum Infectious Diseases ·Emma M. Kileel,Janet Lo,Carlos Malvestutto,Kathleen V. Fitch,Markella V. Zanni,Carl J. Fichtenbaum,Edgar T. Overton,Nwora Lance Okeke,Princy Kumar,Esaú João,Judith A. Aberg,Estebán Martínez,Judith S. Currier,Pamela S. Douglas,Heather J. Ribaudo,Steven Grinspoon	2021	27
12	Excess Patient Visits for Cough and Pulmonary Disease at a Large US Health System in the Months Prior to the COVID-19 Pandemic: Time-Series Analysis Journal of Medical Internet Research ·Joann G. Elmore,Pin‐Chieh Wang,Kathleen F. Kerr,David L. Schriger,Douglas E. Morrison,Ron Brookmeyer,Michael A. Pfeffer,Thomas H. Payne,Judith S. Currier	2020	10
13	Linked dual-class HIV resistance mutations are associated with treatment failure JCI Insight ·Valerie F. Boltz,Wei Shao,Michael J. Bale,Elias K. Halvas,Brian T. Luke,James McIntyre,Robert T. Schooley,Shahin Lockman,Judith S. Currier,Fred Sawe,Evelyn Hogg,Michael D. Hughes,Mary F. Kearney,John M. Coffin,John W. Mellors	2019	13
14	Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy PLoS ONE ·Elizabeth M. Stringer,Michelle A. Kendall,Shahin Lockman,Thomas Campbell,Karin Nielsen‐Saines,Fred Sawe,Susan Cu‐Uvin,Xingye Wu,Judith S. Currier	2018	51
15	A Randomized, Placebo-Controlled Trial of Abacavir Intensification in HIV-1–Infected Adults With Virologic Suppression on a Protease Inhibitor–Containing Regimen HIV Clinical Trials ·Scott M. Hammer,Heather J. Ribaudo,Roland Bassett,John W. Mellors,Lisa M. Demeter,Robert W. Coombs,Judith S. Currier,Gene D. Morse,John G. Gerber,Ana I. Martínez,William Spreen,Margaret A. Fischl,Kathleen Squires,(unknown)	2010	16
16	Sex-Based Outcomes of Darunavir–Ritonavir Therapy: The GRACE (Gender, Race, and Clinical Experience) Study Annals of Internal Medicine ·Judith S. Currier,Dawn Averitt Bridge,Debbie Hagins,Carmen Zorrilla,Judith Feinberg,Robert J. Ryan,Ron Falcon,Alan M. Tennenberg,Joseph Mrus,Kathleen Squires	2010	6
17	Impact of antiretroviral therapy regimen and duration of therapy on risk of mother-to-child HIV transmission in Johannesburg, South Africa Ghent University Academic Bibliography (Ghent University) ·Risa M. Hoffman,Black,Karl‐Günter Technau,K van der Merwe,Judith S. Currier,Matthew Chersich,Ashraf Coovadia	2009	1
18	Report from the 14th Retrovirus Conference. Metabolic complications: lipoatrophy, lipohypertrophy, and cardiovascular risk. PubMed ·Judith S. Currier	2007	2
19	Metabolic Complications: Lipoatrophy, Lipohypertrophy, and Cardiovascular Risk Journal watch ·Judith S. Currier	2007	1
20	Electronic Surveillance of Antibiotic Exposure and Coded Discharge Diagnoses as Indicators of Postoperative Infection and Other Quality Assurance Measures Infection Control and Hospital Epidemiology ·Lisa R. Hirschhorn,Judith S. Currier,Richard Platt	1993	53

About Judith S. Currier

Judith S. Currier is a scholar working on Virology, Emergency Medicine and Infectious Diseases, having authored 294 papers that have together received 12.2k indexed citations. Recurring topics across this work include HIV-related health complications and treatments (141 papers), HIV/AIDS Research and Interventions (117 papers), HIV/AIDS drug development and treatment (106 papers), HIV Research and Treatment (98 papers), Pneumocystis jirovecii pneumonia detection and treatment (29 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (18 papers), Hepatitis C virus research (16 papers) and HIV, Drug Use, Sexual Risk (16 papers). The work is most often cited by research in Virology (5.0k citations), Emergency Medicine (5.8k citations) and Infectious Diseases (7.3k citations). Judith S. Currier has collaborated with scholars based in United States, South Africa and Zimbabwe. Frequent co-authors include Michael D. Hughes, James H. Stein, Kathleen Squires, Scott M. Hammer, Joseph J. Eron, Judith A. Aberg, Judith Feinberg, Margaret A. Fischl, Lisa M. Demeter and Jon C. Cook. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact